A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
Comprehensive, up-front full-panel NGS across lung cancer stages is preferred to conserve tissue and avoid sequential testing ...
Safety and QoL considerations are reshaping sequencing, including avoidance of immunotherapy in certain drivers and adoption ...
"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...
Next-generation sequencing (NGS) is recommended for patients with metastatic prostate cancer (PC). Nationwide, testing rates are low. Whether PC disease characteristics and courses differ between ...
The FDA approved the Oncomine Dx Express Test for rapid identification of NSCLC patients eligible for Zegfrovy treatment. The test provides results in 24 hours, aiding timely therapeutic decisions and ...
Rising demand for early disease detection, expanding oncology applications, and rapid advancements in next-generation sequencing technologies propel market growth at 16.69% CAGR.Austin, United States, ...
CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for ...
When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results